Weill Cornell Medicine Clinical trials info
Please find attached the information about two clinical trials available at WCM. These trials have a novel, selective cortisol receptor blocker for the treatment of ectopic, pituitary, and adrenal Cushing syndrome with overt hypercortisolism (GRACE study). As well as a milder adrenal Cushing SD, where just 1mg Dex test needs to be abnormal (GRADIENT study).
These are phase 3 trials. Also, we have the extension phase for GRACE and are working on getting to our site the extension for GRADIENT study. This will permit patients to utilize the drug beyond the clinical trial, till it becomes available in the market.